Ithaka Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-51,407
| Closed | -$4.38M | – | 37 |
|
2018
Q4 | $4.38M | Sell |
51,407
-2,823
| -5% | -$240K | 0.8% | 30 |
|
2018
Q3 | $5.26M | Sell |
54,230
-4,396
| -7% | -$426K | 0.78% | 30 |
|
2018
Q2 | $5.52M | Sell |
58,626
-1,015
| -2% | -$95.6K | 0.86% | 30 |
|
2018
Q1 | $4.84M | Buy |
59,641
+59,628
| +458,677% | +$4.83M | 0.81% | 30 |
|
2017
Q4 | $5.37M | Sell |
13
-61,751
| -100% | -$25.5B | 0.96% | 30 |
|
2017
Q3 | $5.75M | Sell |
61,764
-3,083
| -5% | -$287K | 1.06% | 31 |
|
2017
Q2 | $5.89M | Sell |
64,847
-18
| -0% | -$1.64K | 1.07% | 32 |
|
2017
Q1 | $5.69M | Sell |
64,865
-3,733
| -5% | -$328K | 1.1% | 33 |
|
2016
Q4 | $5.68M | Sell |
68,598
-14,991
| -18% | -$1.24M | 1.12% | 31 |
|
2016
Q3 | $7.73M | Buy |
83,589
+25,026
| +43% | +$2.32M | 1.22% | 32 |
|
2016
Q2 | $4.56M | Sell |
58,563
-584
| -1% | -$45.4K | 0.66% | 36 |
|
2016
Q1 | $4.88M | Buy |
59,147
+1,801
| +3% | +$149K | 0.7% | 33 |
|
2015
Q4 | $6.01M | Buy |
57,346
+3,489
| +6% | +$366K | 0.8% | 32 |
|
2015
Q3 | $5.67M | Buy |
53,857
+6,569
| +14% | +$692K | 0.87% | 36 |
|
2015
Q2 | $6.47M | Sell |
47,288
-3,073
| -6% | -$420K | 1.09% | 34 |
|
2015
Q1 | $6.28M | Buy |
+50,361
| New | +$6.28M | 0.99% | 33 |
|